Le Lézard
Classified in: Health
Subject: LGB

Fenway Health joins AMAF consortium of institutions to address LGBTQ+ health disparities


The fellowship program aims to provide enhanced physician training, education and cultural sensitivity while bringing awareness to the health care and institutional barriers faced by LGBTQ+ and intersecting communities

BOSTON, Aug. 2, 2022 /PRNewswire-PRWeb/ -- Harvard Medical School affiliated hospitals, Fenway Health, and Vanderbilt University Medical Center join national fellowship initiative

The American Medical Association Foundation (AMAF) announced today that several of Harvard Medical School (HMS)'s affiliated hospitals in collaboration with Fenway Health in Boston, Mass., and Vanderbilt University Medical Center (VUMC) in Nashville, Tenn., will participate in the AMAF National LGBTQ+ Fellowship Program consortium of institutions. They join the pilot fellowship at Icahn School of Medicine at Mount Sinai in New York City, N.Y., and the 2021 inaugural institution at the University of Wisconsin School of Medicine and Public Health in Madison, Wis. Today's announcement marks the next chapter in the Foundation's transformational initiative.

Launched in 2020, the fellowship program aims to provide enhanced physician training, education and cultural sensitivity while bringing awareness to the health care and institutional barriers faced by LGBTQ+ and intersecting communities. The program's ultimate mission is to ensure that all LGBTQ+ patients receive the highest standards of care while helping to transform the landscape of medical education. The addition of two exceptional teaching institutions to the program demonstrates the AMAF's commitment to moving the needle and taking the fellowship to scale nationwide.

"The AMAF is uniquely positioned to serve as a convening force to improve LGBTQ+ health equity by facilitating collaboration and knowledge sharing between key stakeholders and institutional leaders that will transform health care systems to be LGBTQ+ inclusive and affirming," says Dr. William Sternfeld, president of the AMAF Board of Directors. "The result will be a workforce of LGBTQ+ health specialists with a rich body of knowledge that can be shared with all medical schools and health care professionals."

The AMAF Board of Directors approved the recommendation from the Fellowship Commission on LGBTQ+ Health to award two grants as part of the second cycle of applications in effort to amplify and accelerate the impact of the program. The commission noted several factors in its recommendation to accept the HMS-Fenway and VUMC fellowships into the program, such as the extensive network of clinics across HMS affiliates and Fenway Health that serve LGBTQ+ patients from adolescence through older adulthood. HMS also established the Sexual and Gender Minority Health Equity Initiative to teach students foundational clinical skills in LGBTQIA+ health care while exploring the intersections of anti-LGBTQIA+ stigma with racism, ageism and ableism. The fellowship will extend and deepen this foundational work by implementing LGBTQIA+ health training systemwide for fellows, residents and faculty. HMS-affiliated clinical sites participating in the fellowship include Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, and Massachusetts General Hospital. Boston Children's Hospital, Cambridge Health Alliance and Mount Auburn Hospital will serve as supplemental clinical elective sites.

"Our multi-site Harvard Medical School-Fenway Health LGBTQIA+ Fellowship team is honored and thrilled to have the opportunity to join the AMAF National LGBTQ+ Fellowship Program. Now more than ever, we need to equip the next generation of physician leaders in LGBTQIA+ health with the skills to provide comprehensive and affirming care for all LGBTQIA+ populations, across the lifecycle, with a focus on serving marginalized LGBTQIA+ communities," states Jennifer Potter, MD, professor of medicine at Beth Israel Deaconess Medical Center and Harvard Medical School; and director of the LGBTQIA+ Population Health Program and co-chair at The Fenway Institute.

The AMAF Fellowship Commission also recognized VUMC's commitment to personalized medicine and to improving outcomes for LGBTQ+ patients at VUMC and across the U.S. Established in 2012, VUMC's Program for LGBTQ+ Health has a 10-year track record of investing in LGBTQ+ health and promoting national leadership in patient care, education, research and advocacy for the LGBTQ+ community. The clinical LGBTQ+ program at VUMC includes the Clinic for Transgender Health that brings together specifically trained experts to provide and coordinate comprehensive care for transgender and gender-nonconforming adults. The fellowship program will intercalate LGBTQ+ health education with all disciplines and throughout curricula at all levels of learners. VUMC's organizational expertise in data informatics will allow for rapid dissemination of internal and external outcomes.

"We are incredibly excited and grateful to be a part of this consortium, in this group of academic medical centers working together to promote inclusive and personalized care for patients," says Dr. Kyla Terhune, vice president for Educational Affairs at VUMC.

The fellowship initiative is in response to persistent, pervasive disparities regarding access to and quality of health care experienced regularly by LGBTQ+ individuals. Studies show that 80 percent of medical students demonstrate a bias of LGBTQ+ patients, leading to 1 in 5 LGBTQ+ adults avoiding health care services due to fear of discrimination. The result is not just harmful, it is deadly. The AMAF and participating institutions will address these inequities while building on existing foundations of diversity, equity and inclusion strategies that support affirming LGBTQ+ services. The AMAF welcomes individuals, foundations and corporations to join the conversation and connect with the Foundation to ensure all LGBTQ+ Americans have access to medical care.

Media Contact

Christopher Viveiros, Fenway Health, 6177217494, [email protected]

Twitter

 

SOURCE Fenway Health


These press releases may also interest you

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

at 01:30
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...



News published on and distributed by: